-The Business Standard India is not working hard enough on climate change Shortly before World Environment Day on Wednesday, it was reported that the concentration of carbon dioxide in the atmosphere had soared to its highest level in three million years. Data captured by the US National Oceanic and Atmospheric Administration revealed that environmental incidence of the gas mostly responsible for trapping heat had crossed 400 parts per million - a level...

-The Times of India NEW DELHI: No-detention provision in the Right to Education (RTE) Act is being touted as a big barrier towards quality education but a comprehensive report by the HRD ministry has revealed that 25 states already had no-detention policy even before the historical law came into force in 2009. It has also been revealed through analysis of District Information of System of Education data that learning ability in states...

-The Indian Express Concerned about rising levels of air pollution in the city, the Delhi government has commissioned IIT-Kanpur to conduct a comprehensive study of pollution levels and causes. The government plans to use data to formulate a policy to control and reduce air pollution, and initiate a second-generation air action plan. Commissioned last month, the IIT-K study will be the most comprehensive study since the 2007 Central Pollution Control Board and...

-The Hindu   Ranbaxy's fraudulent practices may have jeopardised millions of lives in India, Africa and the U.S. Exactly two weeks ago, the pharmaceuticals industry was rocked by revelations that one of the world's largest generic drug manufacturers, Ranbaxy Laboratories, pleaded guilty to seven federal criminal charges stemming from its fraudulent production practices dating back to 2008, and agreed to pay U.S. regulators $500 million in fines. Much has since been said about Ranbaxy's...

-The Economic Times Japanese companies do not mind erring on the side of caution. They are known to think longer and harder than their counterparts in other countries about big decisions, especially when it comes to entering a new market or acquiring a foreign company. But Japan's third biggest drugmaker Daiichi Sankyo would now wish it had spent more time doing due diligence on Ranbaxy Labs, in which it bought a...